Additionally, lower intensity TNFR2 expression was observed for tumor-infiltrating CD4+Foxp3− and CD8+ Teff cells, and for PBMC-derived Teff cells following in vitro stimulation with PHA-P/IL-2 or specific cognate antigenic peptide (Supplementary Figure S6). The gene discussed is TNFRSF1B; the disease is neoplasm.